Haoxi Health Technology Limited (HAO) Earnings History
Net Loss5 years of earnings data (2021–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
Haoxi Health Technology Limited (HAO) Earnings Overview
As of June 23, 2026, Haoxi Health Technology Limited (HAO) reported trailing twelve-month net income of -$2M, reflecting +24.5% year-over-year growth. The company earned $-0.55 per diluted share over the past four quarters, with a net profit margin of 11.8%.
Looking at the long-term picture, HAO's historical earnings data spans multiple years. The company achieved its highest annual net income of $4M in fiscal 2025, representing a new all-time high.
Haoxi Health Technology Limited is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including BTBT (-$169M net income, -70.7% margin), CLPS (-$4M net income, -4.3% margin), AIXI (-$116M net income, -821.1% margin), HAO has outperformed on profitability metrics. Compare HAO vs BTBT →
HAO Earnings vs Peers
Earnings metrics vs comparable public companies
HAO Historical Earnings Data (2021–2025)
5 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $4M | +200.1% | -$2M | $1.32 | 11.8% | -6.1% |
| 2024 | $1M | +33.2% | $2M | $1.06 | 2.7% | 3.5% |
| 2023 | $969,752 | +296.5% | $1M | $0.09 | 3.4% | 4.2% |
| 2022 | $244,587 | -19.6% | $268,770 | $0.02 | 1.5% | 1.7% |
| 2021 | $304,065 | - | $330,550 | $0.03 | 2.4% | 2.6% |
Download Data
Export HAO earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
5+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
HAO — Frequently Asked Questions
Quick answers to the most common questions about buying HAO stock.
What is HAO earnings per share (EPS)?
HAO trailing twelve-month (TTM) diluted EPS is $-0.55, reflecting +24.5% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2021 to 2025 is available in the table on this page.
What is Haoxi Health Technology Limited's net income?
Haoxi Health Technology Limited (HAO) trailing twelve-month net income is $-2M as of 2025. Earnings grew +24.5% year-over-year. Haoxi Health Technology Limited has been profitable for 5 consecutive years.
Is HAO profitable?
HAO is not currently profitable on a TTM basis, reporting a net loss of $-2M. Net margin is +11.8%. Investors should monitor for a return to profitability.
What is HAO's earnings growth rate?
HAO compound annual EPS growth rates (CAGR): 1-Year: +24.5%, 3-Year: +280.3%, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2021 to 2025.
What are HAO's profit margins?
Haoxi Health Technology Limited net profit margin is +11.8%, operating margin is -6.1%, and gross margin is +2.8%. Margins are within a typical range for the sector. Return on Equity is +27.1%.
Is HAO growing earnings?
Yes, HAO earnings are accelerating — EPS growth of +24.5% exceeds the 5-year CAGR of N/A. TTM net income reached $-2M. Earnings momentum is strengthening.
What was HAO's best earnings year?
Haoxi Health Technology Limited's highest annual net income on record is $4M, achieved in fiscal year 2025. Earnings history on this page spans 2021 to 2025 and includes all annual and quarterly figures.
What were HAO's earnings last quarter?
HAO's most recent reported quarter was Q2 2026. Net income was $-7M with diluted EPS of $-1.53. For a full breakdown of all quarters, see the quarterly earnings table on this page.